Continuation of therapeutic dose heparin for critically ill patients with COVID-19

Charlotte A. Bradbury, Patrick R. Lawler, Bryan J. McVerry, Ryan Zarychanski, on behalf of the REMAP-C. A. P. Investigators, Shailesh Bihari, Allen C. Cheng

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Continuation of therapeutic dose heparin for critically ill patients with COVID-19'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science